By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement with Merck to conduct a diabetes biomarker discovery research project.

The collaboration will use Ezose's GlycanMap platform to identify changes in glycan patterns on post-translationally modified proteins from human subjects. Ezose did not disclose financial or other terms of the agreement but said that it builds on a series of collaborative studies previously conducted with the New Jersey-based drug giant.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.